Latest Manufacturing Facilities News & Updates

Washington, July 22 (IANS) US President Donald Trump has announced that imported generic medicines will remain free of tariffs for two years from August 1, 2026, before facing duties of 100 per cent and later 200 per cent as part of his push to shift pharmaceutical production to the United States.The announcement gives overseas generic drug manufacturers a two-year window to establish production facilities in the US or face steep tariffs on medicines shipped to the American market.“Effective A…